Benjamin Looker wants to improve outcomes for cancer patients. And while he’s not a scientist or a doctor, he’s spent his career contributing to the cause. As the new and first general counsel for Trillium Therapeutics Inc., he’s helping the company as it starts new and expanded clinical trials. Taking the job in April, he […]